Interlinked selected for the 2024 Innovate Nordics Acceleration Program
From challenges to breakthroughs: our journey of innovation, resilience, and impact in healthcare
Interlinked expands global healthcare collaborations: fostering connections in china
ReLink achieves registered trademark status in India, strengthening global commitment to patient safety
Exciting Milestone Achieved: FDA Registration for Innovative Healthcare Solution
Highlights from an Intensive May at Interlinked AB
Recognising progress: our intellectual property rights portfolio expands with a new patent
Gratitude for Recognition: Reflecting on Our Entrepreneurial Journey
Celebrating Milestones: Commencing Our Clinical Trial Journey
Completion of ReLink Randomized Controlled Trial: A Milestone in Healthcare Innovation
Expanding Our Reach: ReLink Patent Approved in Brazil!
Latest patent: This time it is India
We're Health Tech Challengers Finalists!
Official logo of Tada Group & upgraded website
ReLink/LinkUS has entered U.S. clinical trials.
Proud Moment for Tada Group AB: Patent Approval in Mexico
Patent update: This time it is Malaysia
ReLink Reaches Patients: A Landmark Achievement in Healthcare Innovation
ReLink Achieves Milestone as Patients Embrace Innovative Solution!
Pure joy! We are turning 7!